(Q38008136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

chronic renal insufficiency

31 January 2020

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Giovanni Targher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

8 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

372-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2012.79

31 January 2020

exact match

0 references

cites work

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease and the coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Diagnosis and therapy of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-invasive means of measuring hepatic fat content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Liver pathology and the metabolic syndrome X in severe obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Hepatic histology in obese patients undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Traditional and nontraditional cardiovascular risk factors in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Metabolic syndrome pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Emerging risk factors and markers of chronic kidney disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Liver: an alarm for the heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

The significance of serum gamma-glutamyltransferase in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

The adipocyte as an active participant in energy balance and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Liver fat in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Human fatty liver disease: old questions and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Presence of coronary plaques in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Fatty liver index and mortality: the Cremona study in the 15th year of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

The metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

A position statement on NAFLD/NASH based on the EASL 2009 special conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Statins and hepatic steatosis: perspectives from the Dallas Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Relationship between regional fat distribution and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

NASH predicts plasma inflammatory biomarkers independently of visceral fat in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.79

Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22565095

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2012.79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565095%20AND%20SRC:MED&resulttype=core&format=json

release_amovgdhh45etxbzzbtcrkcbfyu

31 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/amovgdhh45etxbzzbtcrkcbfyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference